Recent studies have shown that abnormal activation of NRAS in MS patients could cause abnormal proliferation and activation of various immune cells, leading to severe inflammatory and autoimmune responses (Koch-Henriksen and Magyari 2021). Here, NRAS is linked to myeloid sarcoma.